Local solutions to shorten treatment delays in bladder cancer. Results of a survey among CEJU authors

Bartosz Dybowski^{1

2}

Affiliations

Editorial

Bartosz Dybowski. Cent European J Urol. 2023.

. 2023;76(4):280-282.

doi: 10.5173/ceju.2023.004E. Epub 2023 Nov 27.

Bartosz Dybowski^{1

2}

No abstract available

Keywords: bladder cancer; healthcare system; patient’s path; procedures.

Conflict of interest statement

The authors declare no conflicts of interest.

Can We Go beyond Pathology? The Prognostic Role of Risk Scoring Tools for Cancer-Specific Survival of Patients with Bladder Cancer Undergoing Radical Cystectomy.
Ślusarczyk A, Wolański R, Miłow J, Piekarczyk H, Lipiński P, Zapała P, Niemczyk G, Kurzyna P, Wróbel A, Różański W, Radziszewski P, Zapała Ł. Ślusarczyk A, et al. Biomedicines. 2024 Jul 11;12(7):1541. doi: 10.3390/biomedicines12071541. Biomedicines. 2024. PMID: 39062114 Free PMC article.

1. Witjes JA, Bruins HM, Carrión A, et al. . EAU guidelines on muscle invasive bladder cancer. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6. EAU Guidelines Office, Arnhem, The Netherlands.
1. Russell B, Liedberg F, Khan MS, et al. . A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients. Eur Urol Oncol. 2020; 3: 239-249. - PubMed
1. Erdik A, Cimen HI, Atik YT, et al. . Sarcopenia is an independent predictor of survival in patients undergoing radical cystectomy for bladder cancer: a single-centre, retrospective study. Cent European J Urol. 2023; 76: 81-89. - PMC - PubMed
1. Hladun T, Ratajczak J, Salagierski M. Can we lower the rates of cystectomy complications by modifying risk factors? A review of the literature. Cent European J Urol. 2022; 75: 28-34. - PMC - PubMed